chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A Nurse at our clinic administered an expired dose of vaccine to a child. The nurse entered the vaccine into the electronic system and into registry but when entering into registry he entered the wrong lot number for the PCV 13 vaccine so the system did not catch his expired vaccine data entry.
55 YEAR OLD FEMALE REPORTED TIGHTNESS IN CHEST  AND HEADACHE ABOUT 30 MINUTES AFTER VACCINATION. ON SITE EMS RESPONDED, VITALS BELOW. SHE WAS MONITORED AND RELEASED TO HOME.
Severe pain in left arm lasting several days. Headache lasting several days. Body aches, chills, joint pain, fatigue, lasting roughly 15 hours, starting  roughly 16 hours after injection. Foot and ankle swelling/water retention starting roughly 16 hours after injection, started off mild and getting worse each day.   The most painful part only lasted one day, milder symptoms are still being experienced 4 days later.  Still happy I got the vaccine. Would do it again in a heartbeat.
On 09/18/2000 the patient presented to a physician's office with a varicella-like rash after exposure to wild-type virus at her daycare. The physician reported the patient presented with a cluster of vesicular lesions on her neck that did not have a dermatomal distribution. They appeared like classic  varicella lesions. The physician indicated that he believed "this probably represents partial failure of the immunization". Additional information has been requested.
Weakness, dizzy, staph infection on face 1/4-1/12. Painful at wrist down 1/18 8:00 am. Paralyzed 12:00 ER admit. 9 days hosp disch 1/27 to rehab, discharged home in wheelchair. 2/18.
Benadryl allergy oral tablet twice daily, and one tablet every 24hrs as needed
With the first dose I did have terrible nausea- lasted for three weeks.  On 09/09/2021 That morning I felt bad. I had achy muscles, cough, headache, sore throat. congestion, and fatigue for two days. On the third day I began have shortness of breath-still on going to this day. 09/19/2021 still fatigue, short of breath, but added on horrible nausea, that ended just recently on 10/12/2021.  I still have the fatigue to this day and hard to catch my breathe.
This spontaneous report as received from a nurse refers to 11 year old patient (gender unspecified). On 20-FEB-2014, nurse inadvertently administered ZOSTAVAX, subcutaneous (dose unspecified) to an 11 year old patient for vaccination. It was reported this would have been dose two of the patient's VARIVAX (Merck). Concomitant therapy was unspecified. No adverse effects reported. No product quality complaint was involved. No further information was provided. Additional information has been requested.
Could not drive; Immobilized for 3 days in bed; Fever; Nausea; Arm was tender; Lethargy; Generalized burning pain; This spontaneous case was reported by a patient and describes the occurrence of TENDERNESS (Arm was tender), LETHARGY (Lethargy), PAIN (Generalized burning pain), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not drive) and MOBILITY DECREASED (Immobilized for 3 days in bed) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hysterectomy in 1994. Concurrent medical conditions included Drug allergy (Allergy to Narcotics), Allergy to edible fungus (Allergy to Yeast), Allergy to nuts (Allergy to Peanuts), Allergy to vaccine (Tetanus), Fibromyalgia since 2009, Hypoglycemia since 1980, Hypothyroidism since 2015 and Irritable bowel syndrome since 1980. Concomitant products included LEVOTHYROXINE and ESTRADIOL for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced TENDERNESS (Arm was tender), LETHARGY (Lethargy), PAIN (Generalized burning pain), MOBILITY DECREASED (Immobilized for 3 days in bed), PYREXIA (Fever) and NAUSEA (Nausea). On 19-Apr-2021, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not drive). The patient was treated with PARACETAMOL (TYLENOL) for Pain, Fever, Nausea and Lethargy, at a dose of UNK dosage form; IBUPROFEN ongoing since an unknown date for Fever, Pain, Nausea and Lethargy, at a dose of UNK dosage form; GABAPENTIN ongoing since an unknown date for Pain, Fever, Nausea and Lethargy, at a dose of UNK dosage form and MELOXICAM ongoing since an unknown date for Fever, Nausea, Pain and Lethargy, at a dose of UNK dosage form. On 23-Apr-2021, TENDERNESS (Arm was tender), LETHARGY (Lethargy), PAIN (Generalized burning pain), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Could not drive), MOBILITY DECREASED (Immobilized for 3 days in bed), PYREXIA (Fever) and NAUSEA (Nausea) had resolved.            The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.   This case was linked to MOD-2021-073340 (Patient Link).
2nd dose Moderna 2/12/21 1517 C/o fast heart rate, SOB, ?different? at 1523 Taken to ED
12hr p/vax pt awoke w/severe rt arm pain;no fever, no redness or rash;abated 2 days;
Patient is a 12 m.o. male who presents with seizure-like activity. Pt was in his crib crying and standing when his back arched and his eyes rolled back and he began twitching. Mother reports that the twitching lasted for about a minute. Afterwards, the pt was sleepy, but still crying. Pt was given his first dose of 1.5 mg Ibuprofen (due to the pt teething) prior to onset of symptoms. He has not had a fever recently.
I awoke on Monday, March  8th with a sore throat.  My throat was very red and inflamed and my glands were swollen too.  I went to the  Urgent Care facility for a strep test, which was negative.  The sore throat felt better on Wednesday, March 10th.
p/vax pt exp uncontrollable sneezing; nasal congestion & rhinitis
Patient reported pain in center of black and vision blurry approximately 10 -15 min. Patient with poor color and sweaty.  Patient Pulse OX  77% , HR 50. 1555 - Epinephrine 0.3mg administered IM left thigh. Oxygen  (full face mask) applied at 15L. Patient pulse ox 98%. Patient report still feeling poorly. 1402 - Benadryl 100 mg IM Right Deltoid administered.  1406 - B/P - 125/82 Pulse Ox 98% HR - 56  Oxygen slowly decreased to 5 L. EMS transported to ER
It started earlier in the day, just tired, then around the time stated I got intense chills to the point of shuddering. Ran a slight temperature but it cooks have been all the blankets I was under. With it being about two weeks after the first injection im not sure if it was a reaction or a bug but it was very intense and the same as other reported symptoms but 2nd dose symptoms not first dose.
Headaches, muscle and joint aches, chills, temp of 102.4, no apetite.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A, 030L20A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 01-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided  Treatment medication was not provided by the reporter
itching at the injection site; Swelling at the injection site; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I had a sore arm after receiving the vaccine and lasted about two days. I tested positive for COVID-19 on 8/16/2022 with a home test. I had a sore throat on 08/15/2022. I had a headache and sore throat but that was it. I contacted my doctor and was prescribed PAXLOVID.
1 hour post injection of the above vaccines pt had right arm flapping that lasted for around 10 seconds then onset that evening she started having tic/spasm of right head lurching toward right shoulder, right arm would fly up, happen within seconds, appeared similar to infantile spasms; had multiple inconclusive EEGs, placed on delayed vaccine scheduled due to concern for DTAP (pertussis portion per PCP) causing tics/spasms in children; resulted in admit to hospital to epilepsy monitoring unit, MRI brain, labs, seeing neurologist, epileptologist, hematologist, geneticists in total. This workup lasted 3 months.   Outcome: 3-5 months symptoms resolved slowly. No confirmed diagnosis or cause could be found organically.  Labs revealed high MMA, low B12, low iron, normal homocysteine, did not meet criteria for any diagnosis which led to genetics consult with negative Exome testing, still undiagnosed.
Information has been received from a registered nurse concerning an approximate 9-year-old patient who on 08-OCT-1999 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). In January 2008, the patient developed chickenpox and presented with a low grade fever. The rash was mild, lasting for 3-4 days. No lab work was available. A product quality complaint was not involved. This is one of several reports received from the same source. Additional information has been requested.
Tdap given in L deltoid. ~30 min later her L hand was noticably swollen-not her arm. She was given a Benadryl orally and it resolved.
Mother called to report (1-3-06) event following DTAP #1 given on 11-15-05. Child had no Sx of illness. On 11/17/058 was observed in swing to have "twitching of both legs" and began to scream, twitching subsided-screaming continued for approx. 1 hr. Child transported via ambulance to children hosp. Neuro eval. and seg neg. Dr feels Sx were related to DTAP.
Pt recv vax on unspecified date; within 24 hr pt exp fever (102F); pt imp 3 day.
This case was reported by a pharmacist and described the occurrence of a seizure in a 17 yr old female pt who received hep A vaccine inactivated (Havrix). The pt's medical history was notable for insulin resistance. Prior to the vaccination with Havrix, on 23Sep04, the pt's medical history was negative for seizure, cerebral palsy, neurological handicap, congenital abnormality, diabetes, renal failure, alcohol or drug abuse, or any other CNS conditions. On 23Sep04, at 2:15PM, the pt received the first dose of Havrix (lotVHA805A6). Five minutes following the administration of Havrix, at 2:20PM, the pt felt dizzy and then experienced approx 30 seconds of seizure like activity, characterized as unresponsiveness to verbal commands, eyes rolling backwards, stiff jerking of arms and legs, clenched teeth, and labored breathing. Emergency response was called. At the time of the seizure, 2:20PM, blood pressure was 160/90mm Hg, heart rate was 72 beats per minute and blood glucose was 103. Approx 10 minutes later, at 2:29PM, the pt lost consciousness for approx three seconds. Upon regaining consciousness, the pt remembered the event and did not experience urine or fecal incontinence. At 2:30PM, blood pressure was 110/70 mmHg, heart rate was 60 beats per minute and blood glucose was 85, the pt was transported to the hospital and treated with intravenous fluids. She was treated and released later the same day and was not hospitalized. All the events resolved on 23Sep04. The pharmacist considered that the events were life threatening and jeopardized the pt. The vaccination series with Havrix was discontinued. The reporting pharmacist considered the events to be related to vaccination with Havrix.
weird taste in her mouth/oatmeal-y taste in mouth; nauseous; This is a spontaneous report from a non-contactable nurse.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient reported that she still was very nauseous and took ondansetron (ZOFRAN). Patient also reported having a weird taste in her mouth, not necessarily lost of taste, but an oatmeal-y taste in her mouth. The outcome of the events was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
A 17 year old patient received Flublok, no AE; Initial information was received on 01-Mar-2021 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional.  This case involves a 17-year-old male patient who received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (batch number and expiry date not reported) via an unknown route in an unknown administration site for prophylactic vaccination on an unknown date (a few months from 18th birthday) (product administered to patient of inappropriate age).  The patient's past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  It was unknown if the patient experienced any additional symptoms/events.   The details of medication and reason for taking the medicine was unknown.  It is unknown if there were lab data/results available.  This was a case of actual medication error case due to inappropriate age at vaccine administration (latency same day).  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information available on the batch number for this case.
Blood clots in both legs, right one significant and a significant clot in my right lung. My hemotologist has no explanation for this.
After receiving first dose of COVID-19 vaccine patient began experiencing jaw numbness on both sides and numbness of the arm. Was brought into ED where she denied any slurred speech, headache, chest pain, or shortness of breath. Denied any hives or itchiness, dizziness, or syncope. Blood pressure in the ED was 186/99 30 minutes after shot.
pt recv vax & 5 days later, devel a viral synd which progressed to bilateral weakness in the lower & upper extremities, difficulty walking secondary to unsteadiness in gait, delayed nerve conduction;
The pt experienced redness, swelling, RAT, treated with Advil, Benadryl, cool compresses.
Dizziness, Trouble Breathing, Muscle Soreness, Joint Soreness, Automimmune Disorder, D Tiger Levels showing autoimmune disorder
Sore arm, low grade fever, chills, shivering, dizziness, nausea nausea, fatigue, body aches, headaches. These lasted for 3 days. Day 4 I got dizzy and nauseous again and that is still happening.
Patient contracted COVID after being fully vaccinated. Fever, Cough, Runny Nose, Chills, Fatigue No history of latest pregnancy.  Baby was delivered 9/2021.
Patient began to fill itchy at injection site, on lower back, and left wrist. His throat also felt itchy. His shot was at 10:55AM. Patient alerted us to symptoms at 11:15AM. Patient given 50mg diphenhyramine IM at 11:20AM in left deltoid. His blood pressure at 11:30AM was 144/92, which patient said wasn't abnormal for him. His symptoms did not progress and he was feeling fine other than mild itchiness when he left pharmacy at 11:45AM.
As a person who has never had any kind of allergies--including seasonal allergies--as of the week I received the vaccine, I appear to have developed a new allergy to dust mites. When resting my head against a pillow (especially near the open end of the pillow case), I develop sneezing, complete sinus congestion (to the point I am not able to breathe from either nostril), runny eyes, and similar histamine responses. The symptoms have responded well to diphenhydramine and loratadine, as well as use of allergen-resistant pillowcases, but they have reduced my sleep quality in the weeks since they developed, and I feel this new allergy has negatively impacted my quality of life.
PATIENT STATES HE HAD RASH AROUND THE INJECTION SITE AND NUMBNESS IN HAND.
approx 1 hrs p/inject pt had t102.6, coughing up blood & joint pain; local rxn site; anaphylaxis;
6/28 red, swollen. 6/29 red, swollen. 6/30 increasing in size, red, swollen, welts, warm to touch. MD notes: Onset of erythema and induration right upper arm secondary to tetanus vaccination.  Md ordered KEFLEX and ATARAX.
Two days later I was running fever.  Just to make sure it wasn't a reaction, I self tested for Covid and was positive.
Covered in major hives head to toe, front to back. Given BENADRYL, taken to the emergency dept., given steroids for 3 days and then again went back to ER and put back on steroids for another 5 days on top of BENADRYL for 2 weeks. Cool showers and also re-checked by his pediatrician and referred to allergy specialist who confirmed he is severely allergic to the meningitis vaccine. This reaction lasted two weeks.
The pt experienced edema, redness of injection site. The pt also experienced edema of the face and a light red rash. Treated with Benadryl and cool compresses.
delayed full body rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (delayed full body rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (delayed full body rash). At the time of the report, RASH (delayed full body rash) outcome was unknown.            No concomitant and treatment medications were reported.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 at 09:00 as dose 5 (booster), single (Lot number: GJ5342) at the age of 61 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Seizure" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The vaccine received was yes. Other medication in 2weeks was unknown. COVID 19 Treatment, brand Pfizer, Treatment start date was 30Nov2022, Treatment stop date was 05Dec2022, indication was treatment of COVID-19.
Pt chief complaint: eyes itching since yesterday. client assessed. No swelling, no redness, vision not affected. Client referred to ophthalmalogist.
Case number PHEH2014US019258, is an initial spontaneous report received from a health care professional on 23 Sep 2014, with the follow-up received on 27 Oct 2014. This report refers to an 11 years old female patient. Past medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M13014), at a dose of 0.5 ml intramuscularly on 21 Apr 2014 at 11:32 AM. Post vaccination, on an unknown date, she experienced redness and knot at the injection site. Outcome of the events was reported as complete recovery. Seriousness and causality of the events was not reported. Follow-up received from health care professional on 27 Oct 2014: Updated patient demographics (gender, height and weight), vaccine batch number, dose, route, date and time of vaccination and event outcome.
Eczema flare up has continued since injection and is spreading up to my upper legs above my knees. Eczema  has always only affected the area around my calves and shin.
Started with small welts with white circles noted on arm where vaccine given. Same type welts were then on Left Chest, Right Chest, Neck, Lower jaw, jaw to lips and then seen on Eyebrows - Employee taken to ED- treated with Dexamethasone 10 mg  IM,  Famotidine 20 mg PO, Benadryl 50 mg, Prednisone 50 mg daily for 5 days.